Mariner
PAVM icon

Mariner’s PAVmed PAVM Stock Holding History

Mariner’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-31
Closed -$12K – 2812
2022
Q3 		$12K Buy
+31
New +$17.6K ﹤0.01% 2406

Other funds holding PAVM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
XF
XML Financial Bethesda, Maryland $1.24B AUM 20.4% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Mariner's PAVM Position: Q4 2022 in Review

Mariner sold out of PAVmed (PAVM) in Q4 2022, closing a stake of 31 shares — an estimated $12K sold.

Mariner first reported a position in PAVM in Q3 2022 and held it in 1 quarter. The position peaked at $12K in Q3 2022. 62 funds tracked by Wall St. Rank hold PAVM as of Q4 2022.

  • Mariner reported no remaining PAVmed position as of Q4 2022 after selling out during the quarter.
  • Mariner sold 31 PAVmed shares in Q4 2022, an estimated $12K.
  • Mariner first reported a position in PAVmed in Q3 2022 and held it in 1 quarter.
  • Mariner's PAVmed position peaked at $12K in Q3 2022.
  • 62 funds tracked by Wall St. Rank held PAVmed as of Q4 2022.

Based on Mariner's 13F filing for Q4 2022, filed 14 Feb 2023.